Post

Access to cancer clinical trials remains uneven across Europe. In a new ESMO Open publication, authors including EORTC CEO Denis Lacombe highlight the need to close the "trial access gap" and strengthen support for meaningful academic cancer research. 🔗 www.esmoopen.com/article/S205...